galantamine and sr 144528

galantamine has been researched along with sr 144528 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartolini, M; Belluti, F; Bisi, A; Di Marzo, V; Gobbi, S; Iriepa, I; Ligresti, A; Mahmoud, AM; Montanari, S; Monti, B; Moraleda, I; Naldi, M; Petralla, S; Pruccoli, L; Rabbito, A; Rampa, A; Tarozzi, A	1

Other Studies

1 other study(ies) available for galantamine and sr 144528

Article	Year
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment. European journal of medicinal chemistry, 2019, Sep-15, Volume: 178 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzofurans; Butyrylcholinesterase; Catalytic Domain; Cell Line, Tumor; CHO Cells; Cholinesterase Inhibitors; Cricetulus; Drug Design; Humans; Immunologic Factors; Mice; Microglia; Molecular Docking Simulation; Neuroprotective Agents; Peptide Fragments; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Small Molecule Libraries	2019

Article

Year

Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment.

European journal of medicinal chemistry, 2019, Sep-15, Volume: 178

Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzofurans; Butyrylcholinesterase; Catalytic Domain; Cell Line, Tumor; CHO Cells; Cholinesterase Inhibitors; Cricetulus; Drug Design; Humans; Immunologic Factors; Mice; Microglia; Molecular Docking Simulation; Neuroprotective Agents; Peptide Fragments; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Small Molecule Libraries

2019